Mostrando 10 resultados de: 18
Publisher
Medicina (Argentina)(3)
Parasite Immunology(2)
Acta Tropica(1)
Clinical and Vaccine Immunology(1)
Emerging Infectious Diseases(1)
Área temáticas
Enfermedades(12)
Farmacología y terapéutica(7)
Microorganismos, hongos y algas(7)
Medicina forense; incidencia de enfermedades(4)
Ginecología, obstetricia, pediatría, geriatría(2)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(18)
ODS 17: Alianzas para lograr los objetivos(14)
ODS 5: Igualdad de género(2)
ODS 8: Trabajo decente y crecimiento económico(1)
ODS 9: Industria, innovación e infraestructura(1)
Origen
scopus(18)
Evaluation of different total leishmania amazonensis antigens for the development of a first-generation vaccine formulated with a toll-like receptor-3 agonist to prevent cutaneous leishmaniasis
ArticleAbstract: BACKGROUND Unfortunately, no any vaccine against leishmaniasis has been developed for human use. ThePalabras claves:L.Amazonensis, leishmaniasis, Poly (I:C), Whole-cell vaccineAutores:Bruna F.A., Cargnelutti D.E., Fernandes A.P., Germanó M.J., Lochedino A.L.S., Lozano E.S., Mackern-Oberti J.P., María Fernanda García Bustos, Salomón M.C., Sanchez M.V.Fuentes:scopusDevelopment of a Fluorescent Assay to Search New Drugs Using Stable tdTomato-Leishmania, and the Selection of Galangin as a Candidate With Anti-Leishmanial Activity
ArticleAbstract: Antimonials continue to be considered the first-line treatment for leishmaniases, but its use entailPalabras claves:flavonoids, Fluorescence, galangin, L. (L.) amazonensis, tdTomatoAutores:Buttazzoni Zuñiga V.C., Jorge Diego Marco, Manghera P., María Fernanda García Bustos, Moya Álvarez A., Paola Andrea Barroso, Parodi C.M., Pastrana O.M., Peñalva P.A., Pérez Brandán C., Sosa A.M.Fuentes:scopusAn appraisal of the scientific current situation and new perspectives in the treatment of cutaneous leishmaniasis
ArticleAbstract: Leishmaniasis is a Neglected Tropical Diseases caused by protozoan parasites of the genus LeishmaniaPalabras claves:Current therapy, Cutaneous leishmaniasis, Improved treatment, In vivo assayAutores:Bermúdez J.M., Briones Nieva C.A., Cid A.G., María Fernanda García Bustos, Romero A.I., Villegas M.Fuentes:scopusB-cell profile, B-cell activating factor concentration and IgG levels in human cutaneous and mucosal leishmaniasis
ArticleAbstract: Aims: The aim of this study was to evaluate characteristics of B cells in human tegumentary leismaniPalabras claves:B lymphocytes, B-cell activating factor, Cutaneous leishmaniasis, hypergammaglobulinemia, interferon-gamma, Interleukin-6, Mucocutaneous leishmaniasisAutores:Albareda M.C., Alejandra Beatriz Barrio, Badano N., Castro Eiro M.E., de Elizalde de Bracco M.M., González Prieto A.G., Laucella S.A., María Fernanda García Bustos, Parodi C.M., Pimentel J.Fuentes:scopusAlterations of immunological parameters in an autochthonous case of visceral leishmaniasis from the northwest of Argentina
ArticleAbstract: We report the alterations of immunological parameters of a patient with visceral leishmaniasis causePalabras claves:B-lymphocyte differentiation, cytokines, T-lymphocyte differentiation, Visceral leishmaniasisAutores:Alejandra Beatriz Barrio, Basombŕo M.A., de Bracco M.M.d.E., María Celia Mora, María Fernanda García Bustos, Parodi C.M., Ramos F.Fuentes:scopusAmerican tegumentary leishmaniasis: T-cell differentiation profile of cutaneous and mucosal forms—co-infection with Trypanosoma cruzi
ArticleAbstract: American tegumentary leishmaniasis displays two main clinical forms: cutaneous (CL) and mucosal (ML)Palabras claves:Cutaneous leishmaniasis, Differentiation and memory phenotype, Leishmania–T. cruzi co-infection, Mucosal leishmaniasis, Peripheral T lymphocytesAutores:Alejandra Beatriz Barrio, Baré P., Basombŕo M.A., de Elizalde de Bracco M.M., González Prieto A.G., María Celia Mora, María Fernanda García Bustos, Parodi C.M., Ramos F.Fuentes:scopusImmunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB/c mice against Leishmania (Leishmania) amazonensis infection
ArticleAbstract: Background/Purpose: A proper adjuvant has a relevant role in vaccine formulations to generate an effPalabras claves:BALB/c, Leishmania (Leishmania) amazonensis, Montanide ISA 763, R848, vaccinesAutores:Cargnelutti D.E., Celedon V., Cuello-Carrión F., María Fernanda García Bustos, Morea G., Salomón M.C., Scodeller E.A.Fuentes:scopusImmunological correlates of cure in the first American Cutaneous Leishmaniasis patient treated by immunotherapy in Argentina. A case report
ArticleAbstract: A patient with localized cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis infectioPalabras claves:Immunology, leishmaniasis, TreatmentAutores:Alejandra Beatriz Barrio, Basombŕo M.A., Convit J., María Celia Mora, María Fernanda García Bustos, Ramoneda C.M.P., Ramos F.Fuentes:scopusIn vivo antileishmanial efficacy of miltefosine against Leishmania (Leishmania) amazonensis
ArticleAbstract: Leishmaniasis, a disease caused by parasites of the Leishmania genus, constitutes a significant healPalabras claves:Autores:Alejandra Beatriz Barrio, Basombŕo M.A., Cimino R.O., De Raspi E.M., María Fernanda García Bustos, Parada L.A., Parodi C.M., Prieto G.G., Rubén Marino Cardozo, Soto J., Uncos D.A., Yeo M.Fuentes:scopusLeishmania (L.) amazonensis infection impairs reproductive and fetal parameters in female mice
ArticleAbstract: Leishmaniasis is a group of parasitic zoonotic diseases caused by intracellular protozoans belongingPalabras claves:fertility, infection, leishmaniasis, Mice, reproductionAutores:Cargnelutti D.E., Germanó M.J., Ginevro P.M., María Fernanda García Bustos, Salomón M.C., Sánchez M.B., Scelta J.Fuentes:scopus